Chen, Y.-F.; Le, P.-H.; Huang, S.-C.; Chou, W.-C.; Hsu, J.-T.
Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on “Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553”. J. Pers. Med. 2023, 13, 988.
https://doi.org/10.3390/jpm13060988
AMA Style
Chen Y-F, Le P-H, Huang S-C, Chou W-C, Hsu J-T.
Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on “Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553”. Journal of Personalized Medicine. 2023; 13(6):988.
https://doi.org/10.3390/jpm13060988
Chicago/Turabian Style
Chen, Yi-Fu, Puo-Hsien Le, Shih-Chiang Huang, Wen-Chi Chou, and Jun-Te Hsu.
2023. "Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on “Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553”" Journal of Personalized Medicine 13, no. 6: 988.
https://doi.org/10.3390/jpm13060988
APA Style
Chen, Y. -F., Le, P. -H., Huang, S. -C., Chou, W. -C., & Hsu, J. -T.
(2023). Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on “Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553”. Journal of Personalized Medicine, 13(6), 988.
https://doi.org/10.3390/jpm13060988
